LNTH Lantheus Holdings, Inc.
Healthcare$100.06-2.85%ClosedMarket Cap: $6.51B
As of 2026-05-26
Valuation
P/E (TTM)
22.46
PEG
—
P/B
5.50
P/S
4.34
EV/EBITDA
16.78
DCF Value
$602.54
FCF Yield
5.5%
Div Yield
0.0%
Margins & Returns
Gross Margin
60.5%
Operating Margin
18.8%
Net Margin
18.0%
ROE
24.3%
ROA
11.9%
ROIC
10.8%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $377.3M | 61.2% | $81.3M | $118.4M | $— | — |
| Q4 null | $406.8M | 59.2% | $77.2M | $54.1M | $— | — |
| FY null | $1.54B | 61.1% | $310.8M | $233.6M | $— | — |
| Q3 null | $384.0M | 57.9% | $43.6M | $27.8M | $— | — |
| Q2 null | $378.0M | 63.8% | $88.0M | $78.8M | $— | — |
| Q1 null | $372.8M | 63.8% | $102.1M | $72.9M | $— | — |
| Q4 null | $391.1M | 63.5% | $113.9M | $-11.8M | $— | — |
| FY null | $1.53B | 64.4% | $457.0M | $312.4M | $— | — |
| Q3 null | $378.7M | 63.9% | $133.7M | $131.1M | $— | — |
| Q2 null | $394.1M | 64.9% | $102.7M | $62.1M | $— | — |
| Q1 null | $370.0M | 68.1% | $100.4M | $131.1M | $— | — |
| Q4 2023 | $354.0M | 64.9% | $137.5M | $103.4M | $1.47 | — |